Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 21, 16:00
Avadel Pharmaceuticals Net Income (Quarterly) : 0.02M for Sept. 30, 2025
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 0.02M |
| June 30, 2025 | 9.665M |
| March 31, 2025 | -4.92M |
| December 31, 2024 | -5.043M |
| September 30, 2024 | -2.625M |
| June 30, 2024 | -13.82M |
| March 31, 2024 | -27.34M |
| December 31, 2023 | -28.79M |
| September 30, 2023 | -36.27M |
| June 30, 2023 | -64.43M |
| March 31, 2023 | -30.78M |
| December 31, 2022 | -27.45M |
| September 30, 2022 | -20.15M |
| June 30, 2022 | -63.44M |
| March 31, 2022 | -26.42M |
| December 31, 2021 | -22.30M |
| September 30, 2021 | -22.00M |
| June 30, 2021 | -19.58M |
| March 31, 2021 | -13.44M |
| December 31, 2020 | -11.28M |
| September 30, 2020 | -11.70M |
| June 30, 2020 | 30.87M |
| March 31, 2020 | -0.865M |
| December 31, 2019 | -2.739M |
| September 30, 2019 | -8.864M |
| Date | Value |
|---|---|
| June 30, 2019 | -8.605M |
| March 31, 2019 | -13.02M |
| December 31, 2018 | -63.86M |
| September 30, 2018 | -15.77M |
| June 30, 2018 | -3.438M |
| March 31, 2018 | -12.24M |
| December 31, 2017 | -9.262M |
| September 30, 2017 | 21.68M |
| June 30, 2017 | 28.93M |
| March 31, 2017 | 25.91M |
| December 31, 2016 | 4.734M |
| September 30, 2016 | -19.99M |
| June 30, 2016 | -19.96M |
| March 31, 2016 | -6.058M |
| December 31, 2015 | 76.10M |
| September 30, 2015 | -29.68M |
| June 30, 2015 | -17.40M |
| March 31, 2015 | 11.65M |
| December 31, 2014 | -31.88M |
| September 30, 2014 | -10.05M |
| June 30, 2014 | -21.07M |
| March 31, 2014 | -26.86M |
| December 31, 2013 | 2.472M |
| September 30, 2013 | -6.369M |
| June 30, 2013 | -32.85M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 192.80M |
| Perrigo Co. Plc | 88.50M |
| GH Research Plc | -15.15M |
| Cosmo NV | -- |
| Alkermes Plc | 0.501M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 77.47M |
| Total Expenses (Quarterly) | 77.45M |
| EPS Diluted (Quarterly) | 0.0002 |